MedTrace Logo

Improving Followup of Abnormal Colon Cancer Screening Tests

NCT00436137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2008-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether direct mailings to patients with positive fecal occult blood tests can increase rates of performing followup colonoscopy.

Conditions

Interventions

BEHAVIORAL

Patient mailing

Patient will receive a mailing recommending colonoscopy, followed by telephone outreach

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • Harvard Vanguard Medical Associates

    lead OTHER

Principal Investigators

  • Thomas D Sequist, MD, MPH · Harvard Vanguard Medical Associates

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-03-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00436137 on ClinicalTrials.gov